Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.

Liu K, Xu Q.

Open source

DOI
10.1016/j.intimp.2007.10.002
Published
2007-10-24
Container
Int Immunopharmacol
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2007.10.002,
  title = {Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.},
  author = {Liu K and  Xu Q.},
  year = {2008},
  journal = {Int Immunopharmacol},
  doi = {10.1016/j.intimp.2007.10.002},
  url = {https://doi.org/10.1016/j.intimp.2007.10.002}
}

RIS

TY  - JOUR
TI  - Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.
AU  - Liu K
AU  -  Xu Q.
PY  - 2008
JO  - Int Immunopharmacol
DO  - 10.1016/j.intimp.2007.10.002
UR  - https://doi.org/10.1016/j.intimp.2007.10.002
ER  - 

APA

K, L., & Q., X. (2008). Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2007.10.002

Source records